Back
NovaBay Pharmaceuticals Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
33
NBY
NovaBay Pharmaceuticals
Last Price:
$0.55
Seasonality Move:
-12.03%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Buy |
| 20-day SMA: | 0.58 | Buy |
| 50-day SMA: | 0.58 | Buy |
| 200-day SMA: | 0.62 | Sell |
| 8-day EMA: | 0.58 | Buy |
| 20-day EMA: | 0.58 | Buy |
| 50-day EMA: | 0.59 | Buy |
| 200-day EMA: | 2.19 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 55.44 | Buy |
| Chaikin Money Flow: | 31129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.6) | Buy |
| Bollinger Bands (100): | (0.55 - 0.67) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.60 while NBY 8-day simple moving average is 0.58, which is a Buy signal.
-
The stock price of NBY is 0.60 while NovaBay Pharmaceuticals 20-day SMA is 0.58, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.58 while NBY share price is 0.60, making it a Buy technically.
-
NBY stock price is 0.60 and NovaBay Pharmaceuticals 200-day simple moving average is 0.62, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
33
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.60. The Score for NBY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.5M
Price in USD:
0.60
Share Volume:
153.3K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
9.08
52-Week Low:
0.36
Sell
33
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.60 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.60 while NBY 8-day exponential moving average is 0.58, which is a Buy signal.
-
The stock price of NBY is 0.60 while NovaBay Pharmaceuticals 20-day EMA is 0.58, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.59 while NBY share price is 0.60, making it a Buy technically.
-
NBY stock price is 0.60 and NovaBay Pharmaceuticals 200-day simple moving average is 2.19, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is -0, suggesting NovaBay Pharmaceuticals is a Sell
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 55.44, which suggest NovaBay Pharmaceuticals is overbought
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.54 - 0.6), which suggest NovaBay Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.55 - 0.67), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.